Bharat Biotech's nasal covid vaccine gets DCGI approval for restricted emergency use
New Delhi, Sept 6: The Drugs Controller General of India (DCGI) on Tuesday approved Bharat Biotech's intranasal Covid vaccine for restricted emergency use in those aged above 18 years.